Immunophotonics Announces Appointment of Miguel Zubizarreta to Its Board of Directors
ST. LOUIS, MISSOURI, USA, April 13, 2022 /EINPresswire.com/ -- Immunophotonics, Inc., a clinical-stage biotech company focused on the discovery and development of novel immune-activating drugs in oncology and infectious disease, has strengthened its …